78144228

Information

  • Trademark
  • 78144228
  • Serial Number
    78144228
  • Registration Number
    3311631
  • Filing Date
    July 16, 2002
    22 years ago
  • Registration Date
    October 16, 2007
    17 years ago
  • Transaction Date
    June 26, 2018
    6 years ago
  • Status Date
    May 18, 2018
    6 years ago
  • Published for Opposition Date
    July 31, 2007
    17 years ago
  • Location Date
    April 22, 2014
    10 years ago
  • Status Code
    710
  • Employee Name
    BRODY, DANIEL S
  • Attorney Docket Number
    120776-KBA00
    Attorney Name
    Mainak H. Mehta
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
2000
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: [ Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary products ]
  • GS0051: [ Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely, dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections ]
  • GS0101: [ Diagnostic kits for medical and veterinary purposes comprised of diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, and assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compounds; diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as receptors and enzymes, and to identify antibacterial compounds ]
  • GS0141: [ Jewelry; watches; clocks; and key rings made of precious metal ]
  • GS0161: Publications and printed matter, namely, magazines, brochures and literature pertaining to drug research; stationery; pens, pencils, notebook binders and business cards
  • GS0251: Clothing namely, t-shirts, jumpers, fleece sweaters, jackets, caps and socks, footwear, head wear; and waterproof clothing, namely, t-shirts, jumpers, fleece sweaters, jackets, caps and socks, footwear, head wear
  • GS0421: Pharmaceutical research services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; veterinary laboratory services
  • GS0441: Pharmaceutical advice services and provision of medical information
Case File Event Statements
  • 5/18/2018 - 6 years ago
    49 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Type: CAEX
  • 10/16/2016 - 8 years ago
    48 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 4/22/2014 - 10 years ago
    47 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 4/22/2014 - 10 years ago
    46 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P
  • 4/8/2014 - 10 years ago
    45 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Type: 815F
  • 4/22/2014 - 10 years ago
    44 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/8/2014 - 10 years ago
    43 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 10/16/2007 - 17 years ago
    42 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/31/2007 - 17 years ago
    41 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/11/2007 - 17 years ago
    40 - NOTICE OF PUBLICATION Type: NPUB
  • 6/26/2007 - 17 years ago
    39 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 6/15/2007 - 17 years ago
    38 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 6/13/2007 - 17 years ago
    37 - ATTORNEY REVIEW COMPLETED Type: ATRV
  • 6/13/2007 - 17 years ago
    36 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ
  • 6/13/2007 - 17 years ago
    35 - 1(B) BASIS DELETED; NEW BASIS APPROVED Type: NEWR
  • 5/22/2007 - 17 years ago
    34 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 6/7/2007 - 17 years ago
    33 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 6/5/2007 - 17 years ago
    32 - ASSIGNED TO PETITION STAFF Type: APET
  • 5/22/2007 - 17 years ago
    31 - PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED Type: PDCB
  • 5/22/2007 - 17 years ago
    30 - PAPER RECEIVED Type: MAIL
  • 1/19/2007 - 18 years ago
    29 - EXTENSION 5 GRANTED Type: EX5G
  • 11/29/2006 - 18 years ago
    28 - EXTENSION 5 FILED Type: EXT5
  • 11/29/2006 - 18 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/27/2006 - 18 years ago
    26 - EXTENSION 4 GRANTED Type: EX4G
  • 6/15/2006 - 18 years ago
    25 - EXTENSION 4 FILED Type: EXT4
  • 6/12/2006 - 18 years ago
    24 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/14/2006 - 19 years ago
    23 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/9/2006 - 19 years ago
    22 - EXTENSION 3 GRANTED Type: EX3G
  • 12/7/2005 - 19 years ago
    21 - EXTENSION 3 FILED Type: EXT3
  • 12/7/2005 - 19 years ago
    20 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/20/2005 - 19 years ago
    19 - EXTENSION 2 GRANTED Type: EX2G
  • 6/13/2005 - 19 years ago
    18 - EXTENSION 2 FILED Type: EXT2
  • 6/13/2005 - 19 years ago
    17 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/16/2004 - 20 years ago
    16 - EXTENSION 1 GRANTED Type: EX1G
  • 12/6/2004 - 20 years ago
    15 - EXTENSION 1 FILED Type: EXT1
  • 12/6/2004 - 20 years ago
    14 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/15/2004 - 20 years ago
    13 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/23/2004 - 20 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/3/2004 - 21 years ago
    11 - NOTICE OF PUBLICATION Type: NPUB
  • 1/5/2004 - 21 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/12/2003 - 21 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2003 - 21 years ago
    8 - EMAIL RECEIVED Type: EMRV
  • 10/30/2003 - 21 years ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/16/2003 - 21 years ago
    6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/23/2003 - 21 years ago
    5 - CASE FILE IN TICRS Type: CFIT
  • 3/27/2003 - 21 years ago
    4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/26/2002 - 22 years ago
    3 - NON-FINAL ACTION MAILED Type: CNRT
  • 11/18/2002 - 22 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/14/2002 - 22 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK